REVIEW PAPER
KEYWORDS
ABSTRACT
Borreliosis is the most frequent tick-borne infectious disease in Europe. The discovery of the causative pathogen Borrelia burgdorferi opened the way for the firm diagnosis of diseases in several clinical disciplines. Lyme borreliosis is a multisystem disease. The symptomatology of borreliosis is rich and various and when involves the nervous system is termed neuroborreliosis. Infection causes the classically described triad of meningitis, radiculoneuritis, and cranial neuritis; however, virtually every known neurologic disorder has been blamed on this infection. For most multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer disease, Parkinson disease. Difficulties in making correct diagnosis can result from the long time lag between tick bite and the occurrence of neurological, rheumatological or cardiological symptoms. In the treatment antibiotics play the most important role.
REFERENCES (22)
1.
Coyle PK, Schutzer SE. Neurologic Aspects of Lyme disease. Med Clin North Am 2002; 86: 261-284.
2.
Sokalska-Jurkiewicz M. Borelioza. Służba Zdrowia 2007; 80-83: 41-44.
3.
Zajkowska J, Hermanowska-Szpakowicz T. Nowe aspekty patogenetyczne boreliozy z Lyme. Przegl Epidemiol 2002; 56 supl. 1: 57-67.
4.
Zajkowska J, Grygorczuk S, Kondrusik M i wsp. Patogeneza boreliozy – nowe aspekty. Przegl Epidemiol 2006; 60: 167-170.
5.
Mygland A, Ljo/stad U, Fingerle V, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17: 8-16.
6.
Zajkowska J, Hermanowska-Szpakowicz T, Grygorczuk S i wsp. Neuroborelioza. Pol Przegl Neurologiczny 2006; 2: 13-21.
7.
Zajkowska J, Pancewicz S, Hermanowska-Szpakowicz T. Neuroborelioza. Neur Neurochir Pol 1998; 32: 111-124.
8.
Zajkowska J, Hermanowska-Szpakowicz T, Kondrusik M i wsp. Zespoły neurologiczne w boreliozie z Lyme. Pol Merk Lek 2000; 9: 584-588.
9.
Charles V, Duprez TP, Kabamba B, et al. Poliomyelitis-like syndro-me with matching magnetic resonance features in a case of Lyme neuroborreliosis. J Neurol Neurosurg Psychiatry 2007; 78: 1160-1161.
10.
Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990; 323: 1438-1444. .
11.
Pfister HW, Rupprecht TA. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients. Int J Med Microbiol 2006; 296 (suppl. 40): 11-16. .
12.
Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18: 484-509.
13.
Dumler JS. Molecular diagnosis of Lyme disease: review and meta-analysis. Mol Diagn 2001; 6: 1-11.
14.
Cerar T, Ogrinc K, Cimperman J, et al. Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 2008; 46: 3375-3379.
15.
Grygorczuk S, Pancewicz S, Zajkowska J i wsp. Reinfekcja w boreliozie z Lyme. Pol Merkur Lek 2008; 25: 257-259.
16.
Kaplan RF, Trevino RP, Johnson GM, et al. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 2003; 60: 1916-1922.
17.
Treib J, Fernandez A, Haass A, et al. Clinical and serologic follow-up in patients with neuroborreliosis. Neurology 1998; 51: 1489-1491.
18.
Feder HM, Johnson BJ, O'Connell S, et al. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007; 357: 1422-1430.
19.
Steere A, Coburg J, Glickstein L. The emergence of Lyme disease. J Clin Invest 2004; 113: 1093-1101.
20.
Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008; 70: 992-1003. .
21.
Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345: 85-92. .
22.
Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003; 60: 1923-1930.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.